Lab Notes: Trevena gets $15M triggered by first sale of drug in China; Braeburn launches opioid use disorder drug Brixadi
This week's Lab Notes has details on a new drug launch, a major cash infusion at a biopharm firm, a smaller investment in a medical device company, and more.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: John George Source Type: news